Clinical Genomics Announces Implementation of UNIConnect pMDx™ LIMS
News Jun 03, 2016
Clinical Genomics has announced that it has signed an agreement with UNIConnect LC to implement the company’s Precision Molecular Diagnostics (pMDx™) laboratory information management system (LIMS) in its two laboratories. The software system will facilitate comprehensive automation of all laboratory processes from sample accessioning through final clinical result reporting.
Following an extensive evaluation period, Clinical Genomics selected pMDx based on the system’s fundamental focus on the needs and processes of the molecular diagnostics laboratory and the key quality and operational checks integrated in the LIMS software.
“As a rapidly expanding biotechnology company, we sought a laboratory software provider with proven expertise in the specialized molecular diagnostics space that would have the scale and flexibility to adapt to our needs over time,” said Lawrence LaPointe, Ph.D., President and CEO of Clinical Genomics. “We are confident that the pMDx platform will support our goals by enabling rapid specimen turnaround times, while ensuring high levels of accuracy and automation.”
Clinical Genomics plans to implement pMDx in its molecular diagnostics laboratories in Bridgewater, New Jersey and Sydney, Australia. Dr. LaPointe stated that, “As a growing global company, we value the ability of the pMDx platform to provide our labs with a consistent LIMS in the various markets where we currently operate and also where we anticipate future expansion.”
William S. Harten, UNIConnect Founder and CEO, noted, "Clinical Genomics’ blood-based colorectal cancer detection test has demonstrated strong potential to improve how the disease is currently monitored and managed. We are proud to announce our technology partnership and look forward to supporting their continued growth in the emerging liquid biopsy space. We’re particularly pleased that this relationship will introduce pMDx into the Australia/New Zealand market; UNIConnect systems are already utilized in North America, with deployments in Europe, Asia and Africa. Our relationship with Clinical Genomics will provide local exposure to a robust and growing life sciences community.”
Automating caricatures poses challenges due to the amount of intricate details and shapes involved and level of professional skill required. A team of computer scientists have developed an innovative deep learning-based approach to automatically generate the caricature of a given portrait
efficiently and realistically.
Google has signed an agreement to join CERN's openlab program. openlab is a public-private partnership with companies and other research organizations to develop information and communication technology (ICT) solutions. Google wants to explore possibilities for joint research and development projects in cloud computing, machine learning, and quantum computing.
With machine learning systems now being used to determine everything from stock prices to medical diagnoses, it's never been more important to look at how they arrive at decisions. A new approach out of MIT demonstrates that the main culprit is not just the algorithms themselves, but how the data itself is collected.
Adaptive Designs in Clinical Trials conference 2019
Apr 01 - Apr 02, 2019
International Conference on Cell and Structural biology
Jul 15 - Jul 16, 2019